Valuation: Aprogen Medicines Inc.

Market Cap 42.2B 31.86M 28.45M 26.28M 23.82M 44.55M 3.02B 45.29M 316M 125M 1.58B 120M 117M 5B P/E 2024
-3.44x
P/E 2025 -2.95x
Enterprise Value 179B 135M 121M 112M 101M 189M 12.85B 192M 1.34B 532M 6.73B 508M 497M 21.22B EV / Sales 2024
1.93x
EV / Sales 2025 2.99x
Free-Float
61.67%
Yield 2024 *
-
Yield 2025 -
09-22 Aprogen Biologics Inc. announced that it has received KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
09-22 Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-20 Aprogen Medicines Inc.(KOSE:A007460) dropped from S&P Global BMI Index CI
09-03 Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-02 Aprogen Biologics Inc. announced that it expects to receive KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
08-21 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding from Jade New Technology Association CI
08-14 Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-09 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding from Jade New Technology Association CI
07-26 Aprogen Biologics Inc. announced that it has received KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-23 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding CI
07-14 Aprogen Medicines to Raise 2 Billion Won Through Convertible Bond Issue MT
07-13 Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-13 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding CI
1 day-1.04%
1 week-3.80%
Current month-1.35%
1 month-5.47%
3 months-17.75%
6 months-56.77%
Current year-81.83%
1 week 1,841
Extreme 1841
2,030
1 month 1,841
Extreme 1841
2,335
Current year 1,841
Extreme 1841
11,880
1 year 1,841
Extreme 1841
14,070
3 years 1,841
Extreme 1841
28,410
5 years 1,841
Extreme 1841
94,950
10 years 1,841
Extreme 1841
875,250
Manager TitleAgeSince
Chief Executive Officer 63 2017-12-26
Comptroller/Controller/Auditor 69 2018-03-27
Director TitleAgeSince
Director/Board Member 63 2022-11-28
Director/Board Member 64 2022-07-17
Director/Board Member 62 2023-10-12
Date Insider Type Main position Quantity % Market Cap. Importance
1/17/25 Others 7,673 0.0025% -
1/19/24 Free 101,429 0.0383%
1/19/24 Free 198,187 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%-3.80%-79.77%-87.33% 31.86M
-1.42%-8.59%+14.93%+140.02% 111B
-0.96%-12.81%+7.24%+27.06% 83.61B
-0.75%+1.44%+40.02%+96.69% 63.58B
-1.56%+1.74%+20.75%+80.93% 59.56B
+1.04%-4.96%+86.94%+158.20% 53.59B
-0.66%-6.68%+15.48%+47.92% 33.25B
+3.12%-1.30%+34.20%+88.19% 30.08B
-0.85%-5.53%-8.56%+23.89% 28.51B
+1.90%+1.74%+9.92%+48.82% 26.83B
Average -0.12%-4.13%+14.12%+62.44% 49.01B
Weighted average by Cap. -0.46%-5.14%+25.03%+88.74%

Financials

2024 2025
Net sales 150B 113M 101M 93.48M 84.71M 158M 10.76B 161M 1.12B 445M 5.64B 425M 416M 17.77B 118B 89.05M 79.52M 73.46M 66.58M 125M 8.45B 127M 884M 350M 4.43B 334M 327M 13.96B
Net income -58.08B -43.84M -39.15M -36.17M -32.78M -61.32M -4.16B -62.33M -435M -172M -2.18B -165M -161M -6.87B -70.2B -52.99M -47.32M -43.72M -39.62M -74.12M -5.03B -75.34M -526M -208M -2.64B -199M -195M -8.31B
Net Debt 70.04B 52.87M 47.21M 43.62M 39.53M 73.95M 5.02B 75.17M 525M 208M 2.63B 198M 194M 8.29B 137B 103M 92.42M 85.38M 77.37M 145M 9.82B 147M 1.03B 407M 5.15B 388M 380M 16.23B
Projected Income Statement - Annual - Aprogen Medicines Inc.
Logo Aprogen Medicines Inc.
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Employees
160
Date Price Change Volume
26-10-23 ₩1,900.00 -1.04% 99,154
26-10-22 ₩1,920.00 -1.54% 54,551
26-10-21 ₩1,950.00 -0.15% 57,637
26-10-20 ₩1,953.00 -2.06% 67,641
26-10-19 ₩1,994.00 +0.96% 55,568
  1. Stock Market
  2. Stocks
  3. A007460 Stock